chr5-9050465-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003966.3(SEMA5A):c.2846-8T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,611,948 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_003966.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEMA5A | NM_003966.3 | c.2846-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000382496.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEMA5A | ENST00000382496.10 | c.2846-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_003966.3 | P1 | |||
SEMA5A | ENST00000652226.1 | c.2846-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.00464 AC: 706AN: 152222Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00424 AC: 1056AN: 249284Hom.: 3 AF XY: 0.00442 AC XY: 596AN XY: 134732
GnomAD4 exome AF: 0.00523 AC: 7630AN: 1459608Hom.: 28 Cov.: 30 AF XY: 0.00526 AC XY: 3819AN XY: 725998
GnomAD4 genome AF: 0.00463 AC: 706AN: 152340Hom.: 1 Cov.: 33 AF XY: 0.00474 AC XY: 353AN XY: 74508
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | SEMA5A: BP4, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at